引用本文: 李波. 復(fù)發(fā)肝癌診治現(xiàn)狀及策略. 中國普外基礎(chǔ)與臨床雜志, 2013, 20(5): 469-473. doi: 復(fù)制
版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis, 2005, 25(2):181-200. |
2. | 叢文銘, 吳孟超. 肝癌術(shù)后復(fù)發(fā)發(fā)生機制及臨床病理學(xué)意義[J]. 中國實用外科雜志, 2012, 32(10):809-811. |
3. | Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells[J]. Cell, 2009, 139(7):1315-1326. |
4. | Zhang Y, Li J, Cao L, et al. Circulating tumor cells in hepatocellular carcinoma:detection techniques, clinical implications, and future perspectives[J]. Semin Oncol, 2012, 39(4):449-460. |
5. | Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma:prognosticand therapeutic implications[J]. Ann Surg, 2006, 243(2):229-235. |
6. | 孫建, 簡志祥, 區(qū)應(yīng)亮, 等. 肝癌根治性切除術(shù)后早期復(fù)發(fā)時限和模式的確定及其對預(yù)后的影響[J]. 實用醫(yī)學(xué)雜志, 2011, 27(10):1748-1750. |
7. | Poon RT, Fan ST, Ng IO, et al. Significance of resection marginin hepatectomy for hepatocellular carcinoma:A critical reappraisal[J]. Ann Surg, 2000, 231(4):544-551. |
8. | Kow AW, Kwon CH, Song S, et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma:review of 1 222 cases of hepatectomy in a tertiary institution[J]. Ann Surg Oncol, 2012, 19(7):2246-2255. |
9. | Burak KW. Prognosis in the early stages of hepatocellular carci-noma:Predicting outcomes and properly selecting patients forcurative options[J]. Can J Gastroenterol, 2011, 25(9):482-484. |
10. | Wu TH, Yu MC, Chen TC, et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma[J]. J Surg Oncol, 2012, 105(1):85-90. |
11. | Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis:clinicopathological analysis and survival outcome[J]. Asian J Surg, 2011, 34(2):53-62. |
12. | Ye JZ, Miao ZG, Wu FX, et al. Recurrence after anatomicresection versus nonanatomic resection for hepatocellular carcinoma:a meta-analysis[J]. Asian Pac J Cancer Prev, 2012, 13(5):1771-1777. |
13. | Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitisB-related cirrhosis[J]. J Clin Oncol, 2000, 18(5):1094-1101. |
14. | Tamura Y, Suda T, Arii S, et al. Value of highly sensitive fucos-ylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment[J]. Dig Dis Sci, 2013 Apr 18. [Epub ahead of print]. |
15. | Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expre-ssion is correlated with poor prognosis in hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(8):1403-1407. |
16. | Chen IP, Ariizumi SI, Nakano M, et al. Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy[J]. J Gastroenterol, 2013 Mar 27. [Epub ahead of print]. |
17. | Ahn S, Hyeon J, Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy[J]. Gut Liver, 2013, 7(2):206-212. |
18. | Hyeon J, Ahn S, Lee JJ, et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma[J]. Dig Dis Sci, 2013 Mar 2. [Epub ahead of print]. |
19. | Zhong JH, Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma:A meta-analysis[J]. Hepatol Res, 2010, 40(10):943-953. |
20. | Peng BG, He Q, Li JP, et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Am J Surg, 2009, 198(3):313-318. |
21. | Nitta H, Beppu T, Imai K, et al. Adjuvant hepatic arterial infusionchemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion[J]. World J Surg, 2013, 37(5):1034-1042. |
22. | 廖錦岐, 袁波, 程玉, 等. 不同治療方法對肝癌術(shù)后復(fù)發(fā)的評價[J]. 中國醫(yī)藥科學(xué), 2011, 19(1):46-47. |
23. | Lau WY, Lai EC. Hepatocellular carcinoma:current management and recent advances[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):237-257. |
24. | Zhou YM, Sui CG, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma:a local experience and a systematic review[J]. World J Surg Oncol, 2010, 8:55. |
25. | Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review[J]. Surg Oncol, 2013, pii:S0960-7404(13)00027-3. doi:10.1016/j.suronc.2013.02.009. |
26. | Hu Z, Wang W, Li Z, et al. Recipient outcomes of salvage liver transplantation versus primary liver transplantation:a systematic review and meta-analysis[J]. Liver Transpl, 2012, 18(11):1316-1323. |
27. | Liu F, Yuan D, Wei YG, et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk[J]. Plos One, 2012, 7(8):1-10. |
28. | 方河清, 唐酷, 何敏志. 射頻消融在復(fù)發(fā)性肝癌治療中的應(yīng)用[J]. 肝膽外科雜志, 2012, 20(4):246-247. |
29. | 區(qū)應(yīng)亮, 孫建, 王慧玲, 等. 肝癌根治性切除術(shù)后早期復(fù)發(fā)的治療策略[J]. 廣東醫(yī)學(xué), 2012, 33(5):622-625. |
- 1. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis, 2005, 25(2):181-200.
- 2. 叢文銘, 吳孟超. 肝癌術(shù)后復(fù)發(fā)發(fā)生機制及臨床病理學(xué)意義[J]. 中國實用外科雜志, 2012, 32(10):809-811.
- 3. Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells[J]. Cell, 2009, 139(7):1315-1326.
- 4. Zhang Y, Li J, Cao L, et al. Circulating tumor cells in hepatocellular carcinoma:detection techniques, clinical implications, and future perspectives[J]. Semin Oncol, 2012, 39(4):449-460.
- 5. Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma:prognosticand therapeutic implications[J]. Ann Surg, 2006, 243(2):229-235.
- 6. 孫建, 簡志祥, 區(qū)應(yīng)亮, 等. 肝癌根治性切除術(shù)后早期復(fù)發(fā)時限和模式的確定及其對預(yù)后的影響[J]. 實用醫(yī)學(xué)雜志, 2011, 27(10):1748-1750.
- 7. Poon RT, Fan ST, Ng IO, et al. Significance of resection marginin hepatectomy for hepatocellular carcinoma:A critical reappraisal[J]. Ann Surg, 2000, 231(4):544-551.
- 8. Kow AW, Kwon CH, Song S, et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma:review of 1 222 cases of hepatectomy in a tertiary institution[J]. Ann Surg Oncol, 2012, 19(7):2246-2255.
- 9. Burak KW. Prognosis in the early stages of hepatocellular carci-noma:Predicting outcomes and properly selecting patients forcurative options[J]. Can J Gastroenterol, 2011, 25(9):482-484.
- 10. Wu TH, Yu MC, Chen TC, et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma[J]. J Surg Oncol, 2012, 105(1):85-90.
- 11. Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis:clinicopathological analysis and survival outcome[J]. Asian J Surg, 2011, 34(2):53-62.
- 12. Ye JZ, Miao ZG, Wu FX, et al. Recurrence after anatomicresection versus nonanatomic resection for hepatocellular carcinoma:a meta-analysis[J]. Asian Pac J Cancer Prev, 2012, 13(5):1771-1777.
- 13. Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitisB-related cirrhosis[J]. J Clin Oncol, 2000, 18(5):1094-1101.
- 14. Tamura Y, Suda T, Arii S, et al. Value of highly sensitive fucos-ylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment[J]. Dig Dis Sci, 2013 Apr 18. [Epub ahead of print].
- 15. Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expre-ssion is correlated with poor prognosis in hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(8):1403-1407.
- 16. Chen IP, Ariizumi SI, Nakano M, et al. Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy[J]. J Gastroenterol, 2013 Mar 27. [Epub ahead of print].
- 17. Ahn S, Hyeon J, Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy[J]. Gut Liver, 2013, 7(2):206-212.
- 18. Hyeon J, Ahn S, Lee JJ, et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma[J]. Dig Dis Sci, 2013 Mar 2. [Epub ahead of print].
- 19. Zhong JH, Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma:A meta-analysis[J]. Hepatol Res, 2010, 40(10):943-953.
- 20. Peng BG, He Q, Li JP, et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Am J Surg, 2009, 198(3):313-318.
- 21. Nitta H, Beppu T, Imai K, et al. Adjuvant hepatic arterial infusionchemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion[J]. World J Surg, 2013, 37(5):1034-1042.
- 22. 廖錦岐, 袁波, 程玉, 等. 不同治療方法對肝癌術(shù)后復(fù)發(fā)的評價[J]. 中國醫(yī)藥科學(xué), 2011, 19(1):46-47.
- 23. Lau WY, Lai EC. Hepatocellular carcinoma:current management and recent advances[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):237-257.
- 24. Zhou YM, Sui CG, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma:a local experience and a systematic review[J]. World J Surg Oncol, 2010, 8:55.
- 25. Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review[J]. Surg Oncol, 2013, pii:S0960-7404(13)00027-3. doi:10.1016/j.suronc.2013.02.009.
- 26. Hu Z, Wang W, Li Z, et al. Recipient outcomes of salvage liver transplantation versus primary liver transplantation:a systematic review and meta-analysis[J]. Liver Transpl, 2012, 18(11):1316-1323.
- 27. Liu F, Yuan D, Wei YG, et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk[J]. Plos One, 2012, 7(8):1-10.
- 28. 方河清, 唐酷, 何敏志. 射頻消融在復(fù)發(fā)性肝癌治療中的應(yīng)用[J]. 肝膽外科雜志, 2012, 20(4):246-247.
- 29. 區(qū)應(yīng)亮, 孫建, 王慧玲, 等. 肝癌根治性切除術(shù)后早期復(fù)發(fā)的治療策略[J]. 廣東醫(yī)學(xué), 2012, 33(5):622-625.